DailyDoctor Archive Specialties Get app
Back to the 4 October 2026 edition

Practice changer · 05 of 05

AGA: when to stop surveillance of pancreatic cysts and HCC in older adults

Make stopping surveillance of stable pancreatic cysts and HCC an explicit shared decision based on comorbidity and life expectancy, rather than surveying older patients indefinitely by default.

Guidelines say when to start surveillance of pancreatic cystic lesions and hepatocellular carcinoma, but rarely when to stop, and older patients are increasingly over-surveyed. This AGA Clinical Practice Update offers best-practice advice on stopping.

For pancreatic cysts, it advises counselling against routine surveillance in patients with significant comorbidity, considering discontinuation in those over 65 with cysts of 15 mm or less stable for five years with no worrisome features, and a frank discussion of its questionable value in those over 75 with cysts under 30 mm stable for five years. For hepatocellular carcinoma, surveillance in older adults should be driven by fibrosis stage and risk rather than age alone, continued for cirrhosis of any cause unless life expectancy is under one to two years, and stopped when life expectancy is that short or in Child-Pugh C cirrhosis without transplant options.

The practical change is to make stopping an explicit, shared decision, anchored in comorbidity and life expectancy, rather than surveying indefinitely by default.

  • AGA best-practice advice on when to stop, not just start, surveillance in older adults.
  • Counsel against pancreatic cyst surveillance where significant comorbidity precludes intervention.
  • Consider stopping cyst surveillance in those over 65 with small cysts stable for five years.
  • Base HCC surveillance on fibrosis stage and risk, not age alone.
  • Stop HCC surveillance when life expectancy is under one to two years or in Child-Pugh C without transplant options.

Why it matters

It gives permission and criteria to stop low-value surveillance that exposes frail older patients to harm without benefit.

Don't overread it

These are expert best-practice advice statements, not graded evidence, and each rests on shared decision-making rather than a fixed rule.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

gicancerpancreasmasldcirrhosis

Tomorrow morning, before your first patient

One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app